Myeloma bone disease is still incurable and is characterized by destructive osteolytic lesions causing bone pain, fractures, and hypercalcemia. Our
Pharmatest has received the renewal of its French Tax Credit approval for the years 2021, 2022, 2023. The French Tax
Along with 11,000 other participants, Pharmatest will be taking part of the virtual AACR 2021 Meeting starting on April 10.
LIVE Webinar: To Overcome the Challenges in Cancer Treatment – From Bone Metastasis to Nanotechnology
Pharmatest would like to invite you to the live Webinar on Tuesday 4th May at 4 pm BST (6 pm
A new lead molecule (compound E197) for novel anti-osteoporotic drug has been identified at the Montpellier Cell Biology Research Center
This week on Thursday October 15th our oncology experts will virtually travel and attend the 3rd Annual Advances in Immuno-Oncology
Pharmatest’s projects and safety during the COVID-19 outbreak To ensure the health and safety of Pharmatest’s employees, we have adopted